Sophiris Bio (SPHS) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access SPHS Annual Balance Sheets →
Examining balance sheet movements between Sophiris Bio and Sep 30 2018 reveals how Sep 30 2019 adjusts its asset composition and liability profile.
Quarterly Report, GAAP in USD millions
ITEM
(Sep 30 2019)
(Jun 30 2019) (Mar 31 2019) (Dec 31 2018) (Sep 30 2018)
Assets
Cash & cash equivalent4.25
Available-for-sale Securities, Debt Securities, Current MA2.05
Cash & Short-term Investments6.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current0.71
Total Current Assets7.01
Equipment/Property/Plant Net0.00
Other Assets, Noncurrent0.00
Operating Lease Right Of Use Asset0.09
Total Assets7.10
Liabilities
Accounts Payable, Current AC0.43
Accrued Liabilities, Current AC0.75
Long-term Debt, Current Maturities LO2.67
Other Liabilities, Current0.00
Total Current Liabilities3.93
Long-term debt3.09
Total Long-term Debt3.09
Derivative Liability, Noncurrent DE2.85
Other liabilities, Noncurrent0.00
Operating Lease Liability Current0.09
Total Liabilities9.86
Stockholders' Equity
Common Stock Value131.49
Additional Paid In Capital Common Stock27.46
Retained Earnings / Accumulated Deficit-161.81
Other Equity0.10
Common Stockholder's Equity-2.76
Total Stockholder's Equity-2.76
Liabilities & Stockholder's Equity7.10
4 historic quarters locked

Sign in to unlock the full Sophiris Bio balance sheet history.

About SPHS Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.